The facility is located Meishan City, Sichuan Province, a satellite city of Chengdu. It is focusing on the development, introduction, production, sales and service of medical devices and in vitro diagnostic products. The company is committed to the domestic transformation and production of foreign advanced products and technologies and it also provides contract production of the medical products services to national and international partners.

The first phase of the facility of 4000m2, start production in May, 2022. Meets Chinese GMP certification requirements and ISO13485 is under review.

Second phase of 60 Chinese acres will be launched in 2023